These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18356531)

  • 1. Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis.
    Viswanathan VK; Weflen A; Koutsouris A; Roxas JL; Hecht G
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1165-70. PubMed ID: 18356531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteropathogenic Escherichia coli dynamically regulates EGFR signaling in intestinal epithelial cells.
    Roxas JL; Ryan K; Vedantam G; Viswanathan VK
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G374-80. PubMed ID: 24904077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo.
    Shifflett DE; Clayburgh DR; Koutsouris A; Turner JR; Hecht GA
    Lab Invest; 2005 Oct; 85(10):1308-24. PubMed ID: 16127426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function.
    Viswanathan VK; Koutsouris A; Lukic S; Pilkinton M; Simonovic I; Simonovic M; Hecht G
    Infect Immun; 2004 Jun; 72(6):3218-27. PubMed ID: 15155623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteropathogenic E. coli effectors EspF and Map independently disrupt tight junctions through distinct mechanisms involving transcriptional and post-transcriptional regulation.
    Singh AP; Sharma S; Pagarware K; Siraji RA; Ansari I; Mandal A; Walling P; Aijaz S
    Sci Rep; 2018 Feb; 8(1):3719. PubMed ID: 29487356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EPEC effector EspF promotes Crumbs3 endocytosis and disrupts epithelial cell polarity.
    Tapia R; Kralicek SE; Hecht GA
    Cell Microbiol; 2017 Nov; 19(11):. PubMed ID: 28618099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasion of enteropathogenic Escherichia coli into host cells through epithelial tight junctions.
    Li Q; Zhang Q; Wang C; Li N; Li J
    FEBS J; 2008 Dec; 275(23):6022-32. PubMed ID: 19016848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function.
    McNamara BP; Koutsouris A; O'Connell CB; Nougayréde JP; Donnenberg MS; Hecht G
    J Clin Invest; 2001 Mar; 107(5):621-9. PubMed ID: 11238563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteropathogenic
    Tapia R; Kralicek SE; Hecht GA
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tricellular Tight Junction Protein Tricellulin Is Targeted by the Enteropathogenic Escherichia coli Effector EspG1, Leading to Epithelial Barrier Disruption.
    Morampudi V; Graef FA; Stahl M; Dalwadi U; Conlin VS; Huang T; Vallance BA; Yu HB; Jacobson K
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli.
    Thanabalasuriar A; Koutsouris A; Weflen A; Mimee M; Hecht G; Gruenheid S
    Cell Microbiol; 2010 Jan; 12(1):31-41. PubMed ID: 19712078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinated transient interaction of ZO-1 and afadin is required for pedestal maturation induced by EspF from enteropathogenic Escherichia coli.
    Ugalde-Silva P; Navarro-Garcia F
    Microbiologyopen; 2019 Dec; 8(12):e931. PubMed ID: 31568664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF.
    Nagai T; Abe A; Sasakawa C
    J Biol Chem; 2005 Jan; 280(4):2998-3011. PubMed ID: 15533930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EspF Interacts with nucleation-promoting factors to recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability.
    Peralta-Ramírez J; Hernandez JM; Manning-Cela R; Luna-Muñoz J; Garcia-Tovar C; Nougayréde JP; Oswald E; Navarro-Garcia F
    Infect Immun; 2008 Sep; 76(9):3854-68. PubMed ID: 18559425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein.
    Dean P; Kenny B
    Mol Microbiol; 2004 Nov; 54(3):665-75. PubMed ID: 15491358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier function.
    Long TM; Nisa S; Donnenberg MS; Hassel BA
    Infect Immun; 2014 Jul; 82(7):2802-14. PubMed ID: 24733098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redistribution of tight junction proteins during EPEC infection in vivo.
    Zhang Q; Li Q; Wang C; Li N; Li J
    Inflammation; 2012 Feb; 35(1):23-32. PubMed ID: 21170673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Map, but not EspF, induces breast epithelial cell apoptosis through ERK/DRP-1 pathway.
    Li Y; Zhu Y; Chu B; Liu N; Chen S; Wang J
    Vet Microbiol; 2022 Mar; 266():109367. PubMed ID: 35183820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction.
    Alvarez CS; Giménez R; Cañas MA; Vera R; Díaz-Garrido N; Badia J; Baldomà L
    BMC Microbiol; 2019 Jul; 19(1):166. PubMed ID: 31315566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EspF effector, a bacterial pathogen's Swiss army knife.
    Holmes A; Mühlen S; Roe AJ; Dean P
    Infect Immun; 2010 Nov; 78(11):4445-53. PubMed ID: 20679436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.